RSS SubscribeRevolution’s pancreatic cancer drug doubles survival, boosts quality of life
By Julie Steenhuysen – Reuters
Revolution Medicine’s (RVMD.O) experimental pancreatic cancer pill doubled survival compared with chemotherapy and improved symptoms enough that some patients could resume activities they had previously abandoned, setting a new benchmark for this deadly cancer, researchers reported on Sunday.
Legal Notice / Disclaimer
Ahead of the Herd newsletter, aheadoftheherd.com, hereafter known as AOTH.Please read the entire Disclaimer carefully before you use this website or read the newsletter. If you do not agree to all the AOTH/Richard Mills Disclaimer, do not access/read this website/newsletter/article, or any of its pages. By reading/using this AOTH/Richard Mills website/newsletter/article, and whether you actually read this Disclaimer, you are deemed to have accepted it.
Related posts
May 24, 2026
